Back to results
US 2019/0375789 A1Published application
Immune system modulators
AssigneeCanimguide Therapeutics AB
InventorLeif Håkansson
Life of this patent
Estimating the term…
Abstract
The present invention described herein relates to compositions that interact with molecules that suppress the immune system. More specifically, embodiments described herein concern the discovery, manufacture, and use of compositions that remove immunosuppression the immune system by binding to immunoregulatory peptides that interact with receptors on immune cells, compositions the can stimulate immune cells, and compositions that are cytotoxic to tumor cells.
Claims18
-88. (canceled)
A method of binding a cancer cell or an immune cell with an isolated peptide the method comprising:
- contacting the cancer cell or the immune cell with the isolated peptide, the isolated peptide comprising the amino acid sequence FFVKLS (SEQ ID NO:
- 62), wherein the isolated peptide comprises no more than 30 amino acid residues;
- and
- detecting the binding of said isolated peptide to said cancer cell or immune cell.
1 more element
Dependencies are inferred from the claim text.